Idursulfase
CAS 50936-59-9 1 FDA-DMF supplierBiologic
Overview
Idursulfase is a recombinant formulation of the human enzyme iduronate-2-sulfatase, used to treat Hunter syndrome, a rare, inherited disorder. It works by replacing the deficient or absent enzyme in individuals with the condition, thus helping to reduce the accumulation of glycosaminoglycans.
Therapeutic areas
Metabolic Disorders
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.